Community Academic Profiles–

Marcia L. Stefanick, Ph.D.

Back to Profile

Publication Details

  • Breast cancer after use of estrogen plus progestin in postmenopausal women.

    Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE, Rajkovic A, Schenken R, Hendrix SL, Ravdin PM, Rohan TE, Yasmeen S, Anderson G. N Engl J Med. 2009; 360 (6): 573-87

    Following the release of the 2002 report of the Women's Health Initiative (WHI) trial of estrogen plus progestin, the use of menopausal hormone therapy in the United States decreased substantially. Subsequently, the incidence of breast cancer also dropped, suggesting a cause-and-effect relation between hormone treatment and breast cancer. However, the cause of this decrease remains controversial.

    PubMedID: 19196674

Stanford Medicine Resources:

Footer Links: